Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffit Hassan

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2019
Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With MesotheliomaIdrees Mian, Zied Abdullaev, Betsy Morrow, et al.
JTO Clinical and Research Reports|October 18, 2021
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> GeneAzam Ghafoor, Idrees Mian, Cathy Wagner, et al.
Cancer Research Communications|March 27, 2023
Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic AntibodiesJingyu Zhan, Dong Lin, Nathan Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaRaffit Hassan, Hedy L Kindler, Thierry Jahan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patientsMasanori Onda, Satoshi Nagata, David J FitzGerald, et al.
Science Translational Medicine|October 25, 2013
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressionRaffit Hassan, Andrew C Miller, Elad Sharon, et al.
Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Expression of mesothelin in thymic carcinoma and its potential therapeutic significanceAnish Thomas, Yuanbin Chen, Arlene Berman, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2019
Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With MesotheliomaIdrees Mian, Zied Abdullaev, Betsy Morrow, et al.
JTO Clinical and Research Reports|October 18, 2021
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> GeneAzam Ghafoor, Idrees Mian, Cathy Wagner, et al.
Cancer Research Communications|March 27, 2023
Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic AntibodiesJingyu Zhan, Dong Lin, Nathan Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaRaffit Hassan, Hedy L Kindler, Thierry Jahan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patientsMasanori Onda, Satoshi Nagata, David J FitzGerald, et al.
Science Translational Medicine|October 25, 2013
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressionRaffit Hassan, Andrew C Miller, Elad Sharon, et al.
Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Expression of mesothelin in thymic carcinoma and its potential therapeutic significanceAnish Thomas, Yuanbin Chen, Arlene Berman, et al.
Pageof 15